Significant Ownership of Lind Global Fund III LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Lind Global Fund III LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Lind Global Partners III LLC, its General Partner - Jeff Easton, Managing Member
Manager location
New York, NY

Follow Filing Activity

Follow Lind Global Fund III LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of Lind Global Fund III LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CISS C3is Inc. Common Stock, par value $0.01 per share 10% $2,372,613 1,325,482 Lind Global Fund III LP 28 Jun 2026
DFSC DEFSEC Technologies Inc. Common Shares, no par value 10% $465,402 +$277,731 347,315 +148% Lind Global Fund III LP 18 Aug 2026
IVDA Iveda Solutions, Inc. Common Stock, par value $0.00001 per share 10% $386,038 +$38,362 1,286,794 +11% Lind Global Fund III LP 30 Jun 2026
IBG Innovation Beverage Group Ltd Ordinary Shares, no par value per share 10% $130,725 181,562 Lind Global Fund III LP 16 Mar 2026
BNGO Bionano Genomics, Inc. Common Stock, $0.0001 par value per share 9.4% $1,669,500 +$851,703 1,050,000 +104% Lind Global Fund III LP 31 Dec 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share 6.4% $187,000 -$10,164 212,500 -5.2% Lind Global Fund III LP 30 Sep 2025
NUWE Nuwellis, Inc. Common Stock, par value $0.0001 per share 6.2% $540,540 193,050 Lind Global Fund III LP 03 Aug 2026
SXTP 60 DEGREES PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share 5.4% $277,778 191,571 Lind Global Fund III LP 31 Jul 2026
FBLG FibroBiologics, Inc. Common Stock, $0.00001 par value 5% $78,280 230,234 Lind Global Fund III LP 02 Apr 2026
IBG Innovation Beverage Group Ltd Ordinary Shares, no par value per share 5% $49,964 56,139 Lind Global Fund III LP 31 Mar 2026
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share 5% $272,042 212,500 Lind Global Fund III LP 31 Mar 2026
ENVB Enveric Biosciences, Inc. Common Stock, $0.01 par value 1.4% $70,538 -$148,738 51,866 -68% EASTON JEFF 30 Jun 2026

Schedules 13D/G Reported by Lind Global Fund III LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .